Lapointe R - Search Results

1

MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells.

Sloan JM, Kershaw MH, Touloukian CE, Lapointe R, Robbins PF, Restifo NP, Hwu P. Sloan JM, et al. Among authors: lapointe r. Cancer Gene Ther. 2002 Nov;9(11):946-50. doi: 10.1038/sj.cgt.7700509. Cancer Gene Ther. 2002. PMID: 12386833 Free PMC article.

2

Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.

Touloukian CE, Leitner WW, Robbins PF, Li YF, Kang X, Lapointe R, Hwu P, Rosenberg SA, Restifo NP. Touloukian CE, et al. Among authors: lapointe r. Cancer Res. 2002 Sep 15;62(18):5144-7. Cancer Res. 2002. PMID: 12234976 Free PMC article.

3

Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.

Lapointe R, Royal RE, Reeves ME, Altomare I, Robbins PF, Hwu P. Lapointe R, et al. J Immunol. 2001 Oct 15;167(8):4758-64. doi: 10.4049/jimmunol.167.8.4758. J Immunol. 2001. PMID: 11591807

4

Immunization against endogenous retroviral tumor-associated antigens.

Kershaw MH, Hsu C, Mondesire W, Parker LL, Wang G, Overwijk WW, Lapointe R, Yang JC, Wang RF, Restifo NP, Hwu P. Kershaw MH, et al. Among authors: lapointe r. Cancer Res. 2001 Nov 1;61(21):7920-4. Cancer Res. 2001. PMID: 11691813 Free PMC article.

5

CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells.

Toso JF, Lapointe R, Hwu P. Toso JF, et al. Among authors: lapointe r. J Immunol Methods. 2002 Jan 1;259(1-2):181-90. doi: 10.1016/s0022-1759(01)00513-0. J Immunol Methods. 2002. PMID: 11730853

6

CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.

Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P. Lapointe R, et al. Cancer Res. 2003 Jun 1;63(11):2836-43. Cancer Res. 2003. PMID: 12782589

7

Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.

Chinnasamy N, Chinnasamy D, Toso JF, Lapointe R, Candotti F, Morgan RA, Hwu P. Chinnasamy N, et al. Among authors: lapointe r. Hum Gene Ther. 2000 Sep 1;11(13):1901-9. doi: 10.1089/10430340050129512. Hum Gene Ther. 2000. PMID: 10986562

8

Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes.

Lapointe R, Toso JF, Butts C, Young HA, Hwu P. Lapointe R, et al. Eur J Immunol. 2000 Nov;30(11):3291-8. doi: 10.1002/1521-4141(200011)30:11<3291::AID-IMMU3291>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 11093145 Free article.

9

Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells.

Marroquin CE, Westwood JA, Lapointe R, Mixon A, Wunderlich JR, Caron D, Rosenberg SA, Hwu P. Marroquin CE, et al. Among authors: lapointe r. J Immunother. 2002 May-Jun;25(3):278-88. doi: 10.1097/01.CJI.0000016307.48397.27. J Immunother. 2002. PMID: 12000870 Free PMC article.

10

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.

Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. Hwu P, et al. Among authors: lapointe r. J Immunol. 2000 Apr 1;164(7):3596-9. doi: 10.4049/jimmunol.164.7.3596. J Immunol. 2000. PMID: 10725715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters